DOUG ADAMS
CEO and Founder, SOLX, Inc.

Doug Adams became CEO of SOLX on December 19, 2007 with the acquisition of SOLX from OccuLogix, a company he originally founded in 2000. Mr. Adams has an accomplished history in the ophthalmic industry with more than 25 years experience. Mr. Adams has directed the launch of more than 20 products while holding the position of founder and CEO at several start-up companies, in addition to senior executive positions at a variety of companies including, Summit Technology, Allergan Medical Optics, and Humphrey Instruments. He holds a BBA from the University of Georgia and has completed executive leadership courses from Columbia University, and Wharton School of Business. He has served on industry advisory boards for Boston University and Ocular Surgery News International.

GABRIEL SIMON, M.D., PH.D.
Director of Clinical Research

Director of Ophthalmic Research at the Boston University Photonics Center, Dr. Simon is a board certified ophthalmologist specializing in clinical research. He is the lead developer of the SOLX Glaucoma Treatment System and technologies for the treatment of age related macular degeneration and other related vision disorders. He has developed 70 patents in ophthalmology throughout the last 20 years, including the first photo-titratable gold micro shunt, licensed exclusively to SOLX. Dr. Simon began working with SOLX at the Photonics Center in 2000 and has since directed clinical studies of the SOLX Glaucoma System to treat more than 1000 patients in Europe, Israel and the United States.

Before joining the Boston University Photonics Center in 2003, he was the Medical Director and Research Assistant Professor at the University of Miami, Department of Ophthalmology. From 1994 to 2003, Dr. Simon was the Adjunct Professor at both the Department of Ophthalmology at University of California, Irvine and Department of Ophthalmology at Emory University in Atlanta. In June of 2007, Dr. Simon received a special appointment to the Graduate Faculty of Purdue University.

Dr. Simon received his medical degree from Central University of Barcelona, Spain and conducted his medical training at Bascom Palmer Eye Institute at the University of Miami. He is the honorary member of Barraquer Institute of America (Bogota, Colombia).

BETH HAKE McHALLAM, CPA
Director, Finance and Administration

Beth McHallam joined SOLX shortly after the company was founded in 2000. Ms. McHallam has over 20 years experience in accounting, finance, legal documentation and information technology fields. Her experience includes 4 years experience in public accounting, more than 10 years in various financial management positions in private companies, and over 8 years experience in financial systems integration and support. Ms. McHallam has worked extensively with numerous early stage companies in various technology segments. During her tenure at SOLX, she has completed Merger Agreements with Boston Scientific and OccuLogix. She holds a B.S. in Accounting from the Moorhead State University, Minnesota and a current CPA license from the state of Vermont.

KEVIN J. LaMARCHE
Director, Global Training

Kevin LaMarche has been a leader in the ophthalmic clinical and ophthalmic surgical landscape for the last 20 years. His range of experience encompasses clinical and surgical ophthalmology with a specialization in anterior segment surgical training. His background includes clinical management, study coordination in numerous FDA trials, ophthalmic lecturing, surgical training, sales and marketing. Mr. LaMarche began his ophthalmic career as a surgical assistant and ophthalmic technician. He spent several years as the technical supervisor at the Massachusetts Eye and Ear Infirmary in Boston, and has worked with various innovative ophthalmic companies including EyeSys Technologies, Visx, Inc, LaserVision Centers, Inc, TLC, OccuLogix, Inc and is currently the Director of Training for Solx, Inc.. Mr. LaMarche holds a B.S. in Biology from Worcester State College.

JOSEPH LOWERY
Director, Clinical and Regulatory Affairs

Joseph Lowery brings 20 years of experience in the medical device industry in engineering, clinical and regulatory affairs, product research, marketing, and business development. He is co-inventor on the original U.S. patent for the Titanium Sapphire Laser, one of the key components of the SOLX Glaucoma Treatment System. He developed and launched numerous medical laser- and light-based products in the fields of ophthalmology, dermatology, ENT and GI. He has developed technologies for companies such as Candela, Cynosure, Collagenesis, Lucid Technology and DUSA Pharmaceuticals. Prior to SOLX, Mr. Lowery worked the Bascom Palmer Eye Institute of the University of Miami, School of Medicine where he conducted ophthalmic laser research. To date, his work has resulted in more than 40 scientific publications and presentations. Mr. Lowery holds a B.S. in Mathematics from St. Louis University, a M.S. in Biomedical Engineering from the University of Miami, and a M.B.A. from Northeastern University in Boston.

ABRAHAM MASSOUDA
Director, Operations and Quality

Abe Massouda has more than 25 years of progressively senior level accomplishments in production, operations and executive general management with profit and loss responsibility. His experience spans the electromechanical, medical disposables and medical device industries. Mr. Massouda was previously employed by Cynosure where he was the Senior Executive Vice president of Operations, Kontron Instruments where he was the President and Chief Executive Officer, and Datamedix where he was the Director of Production. Mr. Massouda graduated from the University of Roger William in Rhode Island with a degree in Industrial Engineering.

JASON M. CLEVENGER
Director, R&D Engineering

Jason Clevenger has nine years experience in engineering and research, including experience in the fields of automotive engineering, defense contract systems engineering, and biomedical devices. He has presented clinical and experimental research results at many national meetings, including Association for Research in Vision and Ophthalmology (ARVO) and American Society for Lasers in Medicine and Surgery (ASLMS). In his current role of Director of Research and Development & Engineering at SOLX Inc., Jason is responsible for designing and testing new devices for the treatment of glaucoma, and transitioning these devices into marketable products. He holds a B.S. in Mechanical Engineering from the University of Michigan (Angell Scholar) and a M.S. in Biomedical Engineering from the University of California, Los Angeles.

KIM H. TIETZ
Director, Global Sales and Marketing

Kim H. Tietz has been involved in the genesis of new ophthalmic categories including the successful commercialization of disposable contact lenses and laser vision correction. Formerly a partner and Senior Vice President at Dorland Global, a healthcare advertising and professional relations agency, he spent 17 years providing counsel to leading ophthalmic companies, such as VISX, Zeiss Humphrey, Bausch & Lomb, Ciba Vision, Essilor Ophthalmics and Summit Technology. In 1990, he was awarded the prestigious ADDY Award by the American Advertising Profession for a groundbreaking professional education program targeted at medical technicians. Prior to Dorland Global, Mr. Tietz was the Regional Sales and Marketing Manager for Southern Optical Company where he coordinated sales and education programs aimed at ophthalmologists, optometrists and technicians and represented most major contact lens manufacturers. Mr. Tietz began his career in ophthalmology in 1977 as a National Sales Representative at Aluxa International. Mr. Tietz has studied at the Wharton School of Business and has also completed the Advanced Executive Education Program, Dartmouth College, Amos Tuck School of Business Administration, Hanover, NH.

S.K. McGARVEY, BSc, MBA
Regulatory Consultant

S.KMcGarvey has an extensive career in the Medical Device Field, both as VP of R&D as well as a consultant to all major and many start-up companies in the Ophthalmic and Cardiovascular specialties for more than 25 years. She has successfully taken numerous files through the IDE/PMA and FDA Panel review process, with no file having ever been rejected.

Among first-of-a kind regulatory approvals, Ms. McGarvey directed the project for the first advanced generation Excimer laser approvals, for Autonomous Technologies, a product which was inducted into the NASA Technology Hall of Fame in 2005. McGarvey has been also been active on and provided leadership to many FDA/Industry/Profession collaborative committees for the establishment of standards for various Ophthalmic products.

JUDY LI-WEN LIN
Design and Quality Engineer

Judy Lin graduated from UC Berkeley with a B. S. major in Mechanical Engineering and minor in Business Administration. Ms. Lin worked on several research projects while in Berkeley, specifically manufacturing and combustion engineering. In addition to technical projects, she was also interested in cross-cultural learning, and spent six months in Japan through a studying-abroad program before graduating from Berkeley. After completing undergraduate education, she went on to Massachusetts Institute of Technology to pursue a M.S. in Mechanical Engineering. At MIT she worked on a biomechanics project at Beth Israel Deaconess Medical Center in Boston, where she conducted research to explore the lubrication mechanism of the pleural space through experiments and simulations. Currently working as an engineer in SOLX, Inc, Ms. Lin is involved with product development and quality testing.

Learn More About SOLX:

• About Us
• Message from the President